TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8787251

Group type: EXPERIMENTAL
Intervention: Propofol infusion during cardiopulmonary bypass (CPB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diazepam (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propofol infusion during CPB
Number of subjects: 20
Study: 2108981

Group type: EXPERIMENTAL
Intervention: buserelin (Suprefact, Hoechst, UK, Ltd, Hounslow, Middlesex), 800 micrograms/day by nasal insufflation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: pure follicle stimulating hormone (FSH)
Number of subjects: 46

Group type: COMPARATOR
Intervention: human menopausal gonadotrophin (HMG)
Number of subjects: 46
Study: 7000232

Group type: EXPERIMENTAL
Intervention: Oxprenolol 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30829017

Group type: EXPERIMENTAL
Intervention: Antidepressant drug use in PES group (n=3, 4.1%)
Number of subjects: 2009

Group type: COMPARATOR
Intervention: Antidepressant drug use in non-PES non-glaucoma group (n=21, 1.1%)
Number of subjects: 2009

Group type: EXPERIMENTAL
Intervention: Medications for hypertension in PES group
Number of subjects: 2009

Group type: EXPERIMENTAL
Intervention: Medications for coronary artery disease in PES group
Number of subjects: 2009
Study: 29031582

Group type: EXPERIMENTAL
Intervention: Children's Eating Behavior Questionnaire (CEBQ) subscale: food responsiveness
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Children's Eating Behavior Questionnaire (CEBQ) subscale: slowness in eating
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Children's Eating Behavior Questionnaire (CEBQ) subscale: satiety responsiveness
Number of subjects: 295
Study: 27428294

Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 24460655

Group type: EXPERIMENTAL
Intervention: Deferasirox (9.7 ± 3.0 mg/kg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 22122781

Group type: EXPERIMENTAL
Intervention: Phenolization with curettage
Number of subjects: 51

Group type: COMPARATOR
Intervention: Phenolization alone
Number of subjects: 51
Study: 21187622

Group type: EXPERIMENTAL
Intervention: 1.23% APF gel iontophoresis
Number of subjects: 15

Group type: COMPARATOR
Intervention: Aqueous solution of hydroxyl‐ethyl‐methacrylate and glutaraldehyde
Number of subjects: 15
Study: 17996780

Group type: EXPERIMENTAL
Intervention: Therapeutic activities that mimic activities of daily living (ADL), 1 session per day for 3 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard therapeutic exercises (passive, active assistive, and active range of motion and strengthening exercises), 2 sessions per day for 3 weeks
Number of subjects: 36
Study: 14700505

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 97

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 97
Study: 11782992

Group type: EXPERIMENTAL
Intervention: Median nerve stimulation for 2 hours
Number of subjects: 0
Study: 9684120

Group type: EXPERIMENTAL
Intervention: High-dose branched chain amino acid-enriched solution (additional amount immediately after operation up until postoperative day 7)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-dose branched chain amino acid-enriched solution
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional postoperative hyperalimentation (control group)
Number of subjects: 8
Study: 7601179

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg bid)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Naproxen sodium (550 mg bid)
Number of subjects: 205
Study: 3387419

Group type: EXPERIMENTAL
Intervention: Titrimetric method
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Spectrophotometric method
Number of subjects: 128
Study: 29080920

Group type: EXPERIMENTAL
Intervention: NEPA (netupitant-palonosetron)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Palonosetron
Number of subjects: 0
Study: 28041917

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR) combined with Vocational Rehabilitation (VR)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) combined with Vocational Rehabilitation (VR)
Number of subjects: 131
Study: 25809235

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Psychoeducational control group
Number of subjects: 100
Study: 22923150

Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol with luteal estradiol pre-treatment (daily oral Estradiol Valerate 4 mg from the 21st day until the first day of the next cycle)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Micro dose GnRH agonist protocol
Number of subjects: 116
Study: 21911721

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Pipobroman
Number of subjects: 285
Study: 19018196

Group type: EXPERIMENTAL
Intervention: Repositioning every 4 hours with an appropriate pressure redistribution surface
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repositioning every 2 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 degrees lateral position
Number of subjects: 0

Group type: COMPARATOR
Intervention: 90 degrees lateral position
Number of subjects: 0

Group type: COMPARATOR
Intervention: Semi-Fowler's position
Number of subjects: 0
Study: 16618976

Group type: EXPERIMENTAL
Intervention: Exercise training program (30-60 min/day, 60-70% HR-reserve, 200-400 kcal, 4-5 days/week)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 96
Study: 14695934

Group type: EXPERIMENTAL
Intervention: 30 mg coenzyme Q10
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 100 mg coenzyme Q10
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 10955324

Group type: EXPERIMENTAL
Intervention: DR4/1 peptide injections every 6 weeks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: DR4/1 peptide injections every 8 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 53
Study: 8617186

Group type: EXPERIMENTAL
Intervention: 40 g lactitol in milk chocolate
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 40 g isomalt in milk chocolate
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 30 g isomalt in milk chocolate
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 40 g maltitol in milk chocolate
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 30 g maltitol in milk chocolate
Number of subjects: 59
Study: 8339411

Group type: EXPERIMENTAL
Intervention: 100 mg flosequinan once daily
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: 75 mg flosequinan twice daily
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study: 3722034

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cephradine
Number of subjects: 60
Study: 29723578

Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane (TAP) Block
Number of subjects: 83

Group type: COMPARATOR
Intervention: Epidural
Number of subjects: 83
Study: 26805418

Group type: EXPERIMENTAL
Intervention: 4‐t‐butylcyclohexanol (Eucerin UltraSensitive Soothing Care Dry Skin)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Acetyl dipeptide‐1 cetyl ester (La Roche‐Posay Toleriane Ultra Intense Soothing Care)
Number of subjects: 31
Study: 26597128

Group type: COMPARATOR
Intervention: Continued standard nutritional support
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Protocolised caloric restriction
Number of subjects: 339
Study: 24278923

Group type: EXPERIMENTAL
Intervention: Zirconium oxide healing caps
Number of subjects: 5

Group type: COMPARATOR
Intervention: Titanium healing caps
Number of subjects: 5
Study: 21231989

Group type: EXPERIMENTAL
Intervention: Topical microemulsion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 0
Study: 18336952

Group type: EXPERIMENTAL
Intervention: Genetically modified food products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processed food products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-processed genetically modified products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-genetically modified processed products
Number of subjects: 0
Study: 16492607

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg x kg(‐1) body mass)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: No supplement
Number of subjects: 8
Study: 12943431

Group type: EXPERIMENTAL
Intervention: Cleft lip and palate patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 18
Study: 11044499

Group type: EXPERIMENTAL
Intervention: Vesta system for endometrial ablation
Number of subjects: 234

Group type: COMPARATOR
Intervention: Surgical treatment (rollerball or resection)
Number of subjects: 234
Study: 9175147

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (TNG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazem hydrochloride (DH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trimethaphan camsilate (TC)
Number of subjects: 0
Study: 8465780

Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg daily
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study: 3008669

Group type: EXPERIMENTAL
Intervention: OK‐432
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: PSK
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control
Number of subjects: 178

Group type: COMPARATOR
Intervention: Chemotherapy (VCR, MMC, MTX)
Number of subjects: 178
Study: 31174600

Group type: EXPERIMENTAL
Intervention: BuMA Supreme stent
Number of subjects: 80

Group type: COMPARATOR
Intervention: XIENCE stent
Number of subjects: 80
Study: 30021528

Group type: EXPERIMENTAL
Intervention: Frailty
Number of subjects: 3904

Group type: EXPERIMENTAL
Intervention: >8 diagnoses
Number of subjects: 3904

Group type: EXPERIMENTAL
Intervention: BMI ≥30
Number of subjects: 3904

Group type: EXPERIMENTAL
Intervention: Lower SF-12 physical health composite score
Number of subjects: 3904

Group type: EXPERIMENTAL
Intervention: Lower SF-12 mental health composite score
Number of subjects: 3904

Group type: EXPERIMENTAL
Intervention: Age ≥85 years
Number of subjects: 3904

Group type: EXPERIMENTAL
Intervention: Being recruited in the UK
Number of subjects: 3904

Group type: EXPERIMENTAL
Intervention: Being recruited in Germany 2/Witten
Number of subjects: 3904
Study: 26538364

Group type: EXPERIMENTAL
Intervention: IL-6
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: IL-10
Number of subjects: 330

Group type: COMPARATOR
Intervention: TNF-α
Number of subjects: 330

Group type: COMPARATOR
Intervention: CRP
Number of subjects: 330
Study: 24863250

Group type: EXPERIMENTAL
Intervention: Liquid human milk fortifier (LHMF; provided additional 12mg docosahexaenoic acid (DHA), 20mg arachidonic acid (ARA)/100mL human milk)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control human milk fortifier (HMF; providing no DHA or ARA)
Number of subjects: 150
Study: 22453866

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 8
Study: 20443731

Group type: EXPERIMENTAL
Intervention: Q‐TER(®), 160 mg, once a day for 30 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vitamin E, 50 mg, once a day for 30 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo, once a day for 30 days
Number of subjects: 60
Study: 19057624

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16099630

Group type: EXPERIMENTAL
Intervention: Low fat diet with omega-3 fatty acids (Fish Oil group)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Olive Oil diet (Olive Oil group)
Number of subjects: 31
Study: 12423514

Group type: EXPERIMENTAL
Intervention: Photochemically treated FFP (with amotosalen and UVA light)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard FFP
Number of subjects: 0
Study: 10509550

Group type: EXPERIMENTAL
Intervention: Felodipine-metoprolol combination tablet (Logimax), 5/50 mg daily
Number of subjects: 321

Group type: COMPARATOR
Intervention: Enalapril, 10 mg daily
Number of subjects: 321

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Felodipine-metoprolol combination tablet (Logimax)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 321
Study: 8608476

Group type: EXPERIMENTAL
Intervention: Edmondson's Grades I + II
Number of subjects: 124

Group type: COMPARATOR
Intervention: Edmondson's Grades III + IV
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Histologic grade
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Mitotic index
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Edmondson's grading
Number of subjects: 124
Study: 1563195

Group type: EXPERIMENTAL
Intervention: Temperature measurement (AUC calculated from rectal temperature measurements one to four times a day)
Number of subjects: 191
Study: 4077506

Group type: EXPERIMENTAL
Intervention: Group treatment with the duo formula (12 sessions over 3 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31484661

Group type: EXPERIMENTAL
Intervention: Cellphone-based daily medication and weekly pill refilling reminders in addition to usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 30134283

Group type: COMPARATOR
Intervention: 0.6 mg/kg oxycodone alone (Group C)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg oxycodone + 2.4 μg/kg DEX (Group D1)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg oxycodone + 4.8 μg/kg DEX (Group D2)
Number of subjects: 99
Study: 26659543

Group type: EXPERIMENTAL
Intervention: GHB 25 mg kg(‐1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: GHB 35 mg kg(‐1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 24615681

Group type: EXPERIMENTAL
Intervention: ONO-5334 sustained release tablet (SRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ONO-5334 immediate release tablet (IRT)
Number of subjects: 0
Study: 23047652

Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (1-g capsule)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluconazole (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-polyphenol placebo control beverage
Number of subjects: 0
Study: 20477733

Group type: EXPERIMENTAL
Intervention: Three additional asthma education sessions with a trained IHCW
Number of subjects: 88

Group type: COMPARATOR
Intervention: No additional asthma education
Number of subjects: 88
Study: 17957793

Group type: EXPERIMENTAL
Intervention: Flutamide 250 mg/day
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 16273966

Group type: EXPERIMENTAL
Intervention: Raised bricklaying devices
Number of subjects: 202
Study: 12117482

Group type: EXPERIMENTAL
Intervention: Pneumatic abdomino‐diaphragmatic belt respiratory assistance
Number of subjects: 7

Group type: COMPARATOR
Intervention: Quiet breathing without the belt
Number of subjects: 7
Study: 10049955

Group type: EXPERIMENTAL
Intervention: Lead dust intervention composed of maternal education and biweekly assistance with household cleaning
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Lead dust intervention with regular cleaning (20 or more times throughout the year)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Lead dust intervention
Number of subjects: 113
Study: 7573878

Group type: EXPERIMENTAL
Intervention: New technique of insertion with anterior displacement of the mandible
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional technique of insertion
Number of subjects: 20
Study: 1889697

Group type: EXPERIMENTAL
Intervention: Tetracycline therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 16

Group type: COMPARATOR
Intervention: Atrophic gastritis subjects
Number of subjects: 16
Study: 6211987

Group type: EXPERIMENTAL
Intervention: Minilaparotomy
Number of subjects: 1610

Group type: COMPARATOR
Intervention: Laparoscopy
Number of subjects: 1610
Study: 31655214

Group type: EXPERIMENTAL
Intervention: Toxigenic C. difficile isolates
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: C. difficile strains producing binary toxin (CDT)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Chloramphenicol
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Resistance genes
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: RT018, 002, 017 and 369
Number of subjects: 331
Study: 29861448

Group type: EXPERIMENTAL
Intervention: MAG-DHA (8 × 625 mg softgels daily for 60 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (sunflower oil, 8 × 625 mg softgels daily for 60 days)
Number of subjects: 15
Study: 26758884

Group type: EXPERIMENTAL
Intervention: Tiotropium (TIO) 18 µg once daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Aclidinium (ACL) 322 µg twice daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 13
Study: 24460863

Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 23078181

Group type: EXPERIMENTAL
Intervention: SMS-based mobile epilepsy educational system (MEES) for a 3-month period
Number of subjects: 51
Study: 20579648

Group type: EXPERIMENTAL
Intervention: Cap-fitted colonoscopy (CFC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regular colonoscopy
Number of subjects: 100
Study: 17999239

Group type: EXPERIMENTAL
Intervention: Length of exposure to a stressor (experimental conditions)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 127
Study: 15855902

Group type: EXPERIMENTAL
Intervention: Low-force chiropractic adjustments
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 35
Study: 11996875

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Left-lateral position
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Right-lateral position
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 32
Study: 9431335

Group type: EXPERIMENTAL
Intervention: $5 bill incentive
Number of subjects: 1000

Group type: COMPARATOR
Intervention: $2 bill incentive
Number of subjects: 1000
Study: 8137626

Group type: EXPERIMENTAL
Intervention: LNG-IUD
Number of subjects: 2758

Group type: COMPARATOR
Intervention: Nova T
Number of subjects: 2758
Study: 2505627

Group type: EXPERIMENTAL
Intervention: Local anaesthesia plus sedation
Number of subjects: 19

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 19
Study: 31487749

Group type: EXPERIMENTAL
Intervention: Periodized Stretch Training (PD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-Periodized Stretch Training (NP)
Number of subjects: 16
Study: 28587658

Group type: EXPERIMENTAL
Intervention: Presence of SIJ Bone Marrow Edema (BME)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Presence of MRI structural lesions in patients with SIJ BME
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Mean spinal scores in patients with SIJ structural lesions
Number of subjects: 185
Study: 25754959

Group type: EXPERIMENTAL
Intervention: 20% Intralipid infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 9
Study: 23743969

Group type: EXPERIMENTAL
Intervention: Guayakí Yerba Maté Organic Energy Shot™ (YM; 140 mg caffeine)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Red Bull Energy Shot™ (RB; 80 mg caffeine)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PLA; 0 mg caffeine)
Number of subjects: 6
Study: 21271211

Group type: EXPERIMENTAL
Intervention: Intervention group (142 persons)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (56 persons)
Number of subjects: 198
Study: 19506919

Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Lumbar Fusion
Number of subjects: 152
Study: 16681476

Group type: EXPERIMENTAL
Intervention: 20-mg tadalafil
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 20-mg tadalafil (in subgroup of patients taking it >=3 times per week)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 16302646

Group type: EXPERIMENTAL
Intervention: Oral 17beta oestradiol (1 mg) and norethisterone (0.5 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 11305707

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9430805

Group type: EXPERIMENTAL
Intervention: Compression of all compartments (calves, thighs, low abdomen, calves and thighs, and all compartments combined) using a modified antigravity suit
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Compression of abdomen
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Compression of all compartments
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Compression of legs alone
Number of subjects: 14
Study: 8297644

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 357

Group type: COMPARATOR
Intervention: Surgery only (no radiotherapy)
Number of subjects: 357
Study: 3430498

Group type: EXPERIMENTAL
Intervention: In-hospital management and nitrofurantoin suppression
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nitrofurantoin suppression
Number of subjects: 100
Study: 29660937

Group type: EXPERIMENTAL
Intervention: Art intervention (singing and painting groups) for 12 weeks
Number of subjects: 50
Study: 27743617

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR)
Number of subjects: 1252

Group type: COMPARATOR
Intervention: Open Repair
Number of subjects: 1252